4 weeks Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of “Buy” by AnalystsMarketBeat
Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are covering the company, Marketbeat reports. Six equities research analysts have rated the…
X